A cell and gene therapy shipment needs more than a collection time and a delivery address. It needs a clear plan for maintaining the required conditions, identifying the material correctly and managing every transfer of responsibility.
For manufacturers, biotechnology companies, research organisations and treatment centres, the challenge is coordinating these requirements across the entire journey. Packaging, transport, documentation and receiving arrangements need to work together.
A shipment arriving on time is important. Having the records needed to assess its condition and confirm its identity is equally important.
At Reefer Express, our cell and gene therapy logistics services bring together temperature-controlled packaging, shipment monitoring, project coordination and support tailored to the shipment’s requirements.
This guide explains what a well-planned cell and gene supply chain should address and what to discuss before choosing a logistics partner.
What Is Cell and Gene Therapy Logistics?
Cell and gene therapy logistics involves coordinating the movement and handling of materials and products used in these therapies. Depending on the programme, shipments may move between collection centres, laboratories, manufacturing facilities, storage locations and treatment sites.
The journey differs by product. Patient-derived cellular gene therapies can involve collecting cells, modifying them outside the body and returning them to the patient. Other gene therapy products use different approaches, including delivery through vectors. They should not all be treated as the same type of shipment. FDA overview of gene therapy
The logistics plan should therefore begin with the product’s requirements, not a standard courier service.
Why the Therapy Model Matters
Autologous cell therapies use a patient’s own cells, while allogeneic cell therapies use cells from a donor. This distinction affects how material is identified and how movements are coordinated. FDA guidance discusses these differences for CAR T-cell products. FDA CAR T-cell guidance
Before planning transport, establish exactly what is moving: starting material, an intermediate product, a finished therapy or a testing sample.
Also confirm which stage comes next. Delivery to a manufacturing facility creates different coordination needs from delivery to a hospital receiving team.
This early discussion helps avoid an unsuitable transport arrangement being selected simply because it worked for another shipment.
Temperature Requirements Must Be Product-Specific
There is no single transport temperature that applies to every cell and gene therapy product.
The manufacturer’s or sponsor’s documented requirements should determine the shipping conditions. These may involve refrigerated, frozen or cryogenic transport, depending on the material and its supporting stability data.
Storage conditions and permitted transport conditions also need to be distinguished. A general description such as “keep cold” is not an adequate shipping specification.
Health Canada’s guidance explains that transport conditions should follow labelled requirements or conditions supported by appropriate data. This is a useful technical principle, although the regulations applicable to a particular shipment depend on its jurisdiction. Temperature-control guidance
Chain of Identity and Chain of Custody Serve Different Purposes
Traceability involves two related controls: chain of identity and chain of custody.
Chain of Identity
Chain of identity maintains the connection between the source material, the resulting product and, where applicable, the intended patient.
For patient-specific shipments, that connection needs to remain clear throughout the process. FDA CAR T-cell guidance emphasises documented labelling and tracking from collection through administration. FDA guidance on product identity
Chain of Custody
Chain of custody records who had responsibility for the shipment, where it was transferred and when each handover occurred.
For a logistics brief, ask how collection, carrier transfers and final receipt will be recorded. Also establish who investigates a missing signature or an unexplained gap.
Together, these controls help answer two different questions: “Is this the correct material?” and “Who handled it?”
Packaging Should Be Qualified for the Planned Journey
Temperature-controlled packaging needs evidence that it can perform under the intended shipping conditions.
The complete packing arrangement matters. The container, coolant, product load, internal protection and monitoring-device position all influence performance.
WHO guidance on shipping-container qualification considers factors including transport duration, acceptable temperature range, payload and external temperature conditions. It also addresses evaluating performance on relevant transport routes. WHO shipping-container qualification guidance
When discussing packaging, ask which configuration has been assessed and whether it matches the planned shipment. A container’s stated performance should not be assumed to apply to every load or route.
For cryogenic shipments, the suitability and condition of the selected shipping system require particular attention. The use of specialised equipment does not remove the need for product-specific procedures.
Reefer Express’s packaging and distribution services can form part of this planning discussion.
Monitoring Should Support Action During Transit
Knowing a shipment’s location is useful, but location tracking alone does not establish whether its temperature requirements have been maintained.
The monitoring plan should explain what is measured, how it is recorded and when the information becomes available.
WHO provides separate guidance on temperature and humidity monitoring systems for transport operations, reflecting the importance of selecting monitoring arrangements suited to the shipment. WHO transport-monitoring guidance
When reviewing a proposed service, ask whether temperature readings are available during transit or downloaded after arrival. Clarify any connectivity limitations and how records are retained.
Equally important is the response process. Who receives an alert? Who contacts the carrier? Who informs the customer’s quality team?
A useful monitoring service connects information with a named person responsible for acting on it.
Plan the Whole Route, Including Waiting Time
A shipping plan should cover the complete journey, not just the time spent in a vehicle or aircraft.
For example, a road-and-air shipment may involve collection, airport acceptance, handling before departure, a flight connection, destination processing and final delivery.
WHO’s transport-route qualification guidance provides a framework for assessing the conditions encountered along distribution routes. WHO transport-route guidance
For a proposed movement, review where waiting could occur and how the shipment will be handled at those points. Confirm receiving hours, site access arrangements and the availability of the final recipient.
A practical contingency discussion should also cover a missed connection, a vehicle problem or an unavailable receiving team. Agree on the escalation process before dispatch, while there is time to assess alternatives.
Final Delivery Requires a Controlled Handover
Delivery planning should identify the actual receiving department and authorised recipient, rather than relying only on a hospital or laboratory’s main address.
The receiving team needs the information required to check the shipment and move it into the appropriate storage conditions.
WHO’s good storage and distribution practices address shipment records, product traceability, review of relevant transport-temperature data and reporting of damage or deviations. WHO good storage and distribution practices
Discuss these arrangements before collection. Confirm how proof of delivery, condition checks and monitoring records will reach the relevant people.
Physical delivery and approval for further use are separate steps. Responsibility for each should be clear.
What Happens if a Temperature Excursion Occurs?
A temperature excursion is a departure from the specified temperature conditions. It requires documented assessment—not an assumption that the product is acceptable because it looks unchanged or has returned to the required temperature.
Follow the agreed deviation procedure, notify the responsible parties and preserve the monitoring record. The authorised quality team should assess the event using relevant product data and determine the appropriate disposition.
Health Canada’s guidance similarly calls for evidence-based investigation and decisions on affected products. Guidance on temperature excursions
Documentation and Compliance Need Early Attention
The documentation required for a shipment depends on the material, its intended use, the countries involved and the transport method.
A logistics plan should identify who is responsible for confirming applicable requirements and preparing the necessary records. For international movements, establish responsibility for import and export documentation before booking transport.
Air shipments may also require dangerous-goods assessment. Where applicable, classification, packaging, marking and documentation must be addressed under the relevant rules and carrier requirements. IATA’s dangerous-goods resources explain the framework used for air transport. IATA dangerous-goods information
Do not assume that all biological shipments have the same classification. Obtain shipment-specific advice from appropriately qualified personnel.
How to Evaluate a Cell and Gene Therapy Logistics Partner
A useful proposal should explain how the shipment will be handled, not simply state that specialist transport is available.
Use the following questions to make discussions more specific:
| Area to assess | What to ask |
| Product requirements | What information do you need before recommending a service? |
| Packaging | What evidence supports this configuration for our shipment? |
| Monitoring | What data will we receive, and when? |
| Handover records | How will each transfer of responsibility be documented? |
| Disruption response | Who will manage delays or alerts outside normal working hours? |
| Delivery | How will you coordinate with our authorised receiving team? |
| Service scope | Which tasks are included, excluded or handled by another party? |
Ask for responsibilities to be agreed in writing. Where several providers are involved, clarify who coordinates the overall movement and who makes decisions at each stage.
Price matters, but compare quotations on equivalent service scopes. A lower transport charge may not include the same packaging, monitoring, coordination or reporting arrangements.
How Reefer Express Supports Cell and Gene Therapy Logistics
Reefer Express offers cell and gene supply chain services focused on shipment visibility, temperature-controlled packaging, project management and customer support.
Personalised Project Planning
Our service approach recognises that different products have different logistics requirements. We work with customers to develop a plan around the material being shipped, the destination and the required handling conditions.
The initial discussion should establish both the customer’s expectations and the agreed limits of the service.
Shipment Monitoring
Reefer Express offers shipment tracking and monitoring support to provide visibility into location and status.
For each project, customers should confirm the monitoring arrangement, reporting method and escalation contacts so that expectations are clear before collection.
Temperature-Controlled Packaging
Our cell and gene supply chain offering includes temperature-controlled packaging solutions.
Selecting the appropriate arrangement starts with the product specification and the proposed journey. Packaging requirements should be discussed alongside transit time and receiving conditions.
Support and Coordination
Reefer Express offers 24/7 support and project coordination for sensitive shipments, alongside assistance with understanding shipment-related regulatory requirements.
Customers can also discuss related healthcare logistics and pharmaceutical supply chain services where their project involves additional movements.
What to Share When Requesting a Logistics Plan
A clear brief helps the logistics team assess the request and identify missing information early.
Start with a description of the material, its shipment stage and its documented transport requirements. Include the collection and delivery locations, expected shipment size, proposed dates and required arrival window.
Explain any special receiving arrangements and identify the operational and quality contacts for the project. For international shipments, clarify which parties are handling customs and regulatory documentation.
If some requirements are still being finalised, state that clearly. The proposal should distinguish confirmed information from assumptions that need approval.
Avoid sending unnecessary patient-identifying information through a general enquiry form. Agree on the appropriate information-sharing process where sensitive data is involved.
Frequently Asked Questions
Do all cell and gene therapy shipments require cryogenic transport?
No. The required conditions depend on the specific material or product. The shipping arrangement should follow its documented requirements.
Is GPS tracking enough to monitor a temperature-sensitive shipment?
No. Location information and temperature information serve different purposes. Confirm how both will be captured and reported when required.
Can one shipping plan be used for every product?
Not without assessment. Differences in product requirements, packaging, route and receiving arrangements may require a different plan.
Does a delivery signature confirm that a therapy is suitable for use?
No. A signature records receipt. Any required condition review and quality decision must follow the applicable procedures.
Does Reefer Express offer customised logistics support?
Yes. Reefer Express’s cell and gene supply chain services include personalised project planning, shipment monitoring, temperature-controlled packaging and support. The exact scope should be agreed for the proposed shipment.
Discuss Your Shipment With Reefer Express
A well-planned cell and gene supply chain connects product requirements with practical transport arrangements. It makes responsibilities clear before dispatch and provides a defined process for handling changes during the journey.
If you are planning a shipment, share your requirements with Reefer Express to discuss packaging, monitoring, coordination and delivery options.
Visit our cell and gene supply chain service page or contact our team.
Email: contact@reefer-ex.com
Phone: +91 8555971022
This article provides general logistics information. Product-specific instructions, applicable regulations and authorised quality procedures take precedence.
